Concepedia

Cécile Pétigny-Lechartier

CP

3

Publications

140

Citations

3

H-Index

2014

Active since

Affiliations

Université de Caen Normandie(Current)

Centre François Baclesse

Normandie Université

Cécile Pétigny-Lechartier is an author at Université de Caen Normandie specializing in tumor biology, medicine, and ovarian cancer.

Top concepts

MedicineCell BiologyTumor BiologyCancer BiologyOvarian CancerCell DeathPharmacologyCancer Cell BiologyOncologyApoptosis

Publications per year

2014–2016

3

Publications

3

PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced

Abdelghani Jebahi, Marie Villedieu, Cécile Pétigny-Lechartier et al. · Cancer Letters · 2014 · 53 citations · Full text

Medicine, Pi3k/mtor Dual Inhibitor, Immunology +12

The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737

Cécile Pétigny-Lechartier, Charlène Duboc, Abdelghani Jebahi et al. · Molecular Cancer Therapeutics · 2016 · 45 citations

Oncology, Chemoprevention Strategy, Medicine +15

First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-x<sub>L</sub>-Targeting Strategies

Céline Gloaguen, Anne Sophie Voisin‐Chiret, Jana Sopková‐de Oliveira Santos et al. · Journal of Medicinal Chemistry · 2015 · 42 citations

Apoptosis Control Defects, Molecular Biology, Cancer Biology +16

Rows per page

1–3 of 3